A multiomic approach to prediction, causation, and prevention of preterm birth and preeclampsia

A multiomic approach to prediction, causation, and prevention of preterm birth and preeclampsia

Recent advances in both genomics, transcriptomics, and proteomics have allowed for the development of novel technologies with greater capabilities for biomarker profiling and discovery. When coupled with high-content data analysis, these multiomic approaches have allowed researchers to generate high-efficiency data to enable new correlations and insights between the genome, transcriptome, and proteome at a molecular level in health and disease. For example, an area of unmet need where multiomics is poised to impact significantly is pregnancy-related complications, such as preterm birth and preeclampsia. A better understanding of the molecular mechanisms of feto-maternal changes during pregnancy could help save lives and improve birthing processes.

Our distinguished presenters — members of the Gaudillière lab at Stanford University — describe how they employed a translational approach that combines single-cell mass cytometry with high-plex proteomic and metabolomic analyses to study the role of the human immune system in the pathobiology of fundamental clinical problems, including pregnancy pathologies. The presenters also explain how they used novel machine-learning methods to train multiomic models and identify biologically relevant predictive biomarkers to develop robust diagnostics rooted in a precise understanding of underlying pathobiological mechanisms.

Ina Stelzer, PhD Instructor Stanford University

Ina Stelzer, PhD

Instructor
Stanford University

Julien Hedou Data Analyst Stanford University

Julien Hédou, MSc

Data Analyst
Stanford University

Dorien Feyaerts, PhD Postdoctoral Fellow Stanford University

Dorien Feyaerts, PhD

Postdoctoral Fellow
Stanford University

A multiomic approach to prediction, causation, and prevention of preterm birth and preeclampsia

A presentation by Ina Stelzer, PhD, Julien Hédou, MSc, and Dorien Feyaerts, PhD

Share with colleagues

More webinars

WebinarDetecting growing tumors through changes in the plasma proteome 

In this GEN webinar, Nebojsa Janjic, PhD, will discuss the need for a reliable blood-based screening method capable of detecting cancers earlier. During the webinar, he will highlight results from a study involving researchers from SomaLogic and the University of Colorado School of Medicine that used a test capable of measuring 5000 proteins simultaneously.

Learn more

WebinarIdentifying Biomarkers for IBD Diagnosis and Management 

In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.

Learn more

WebinarBoutique Webinar : Predicting Pregnancy Complications with High-Plex Proteomics

The interdisciplinary team, comprising 10-15 scientists and clinician-scientists, is dedicated to advancing diagnostics and therapeutics aimed at enhancing maternal and fetal care. Their primary focus lies in the development of interventions for conditions such as ectopic pregnancy and preeclampsia, alongside the creation of diagnostics to prevent stillbirth.

Learn more

Explore webinars in our interactive viewer